99 related articles for article (PubMed ID: 4966140)
21. Early immunoglobulin formation and hemagglutinating and bactericidal titers in Erythrocebus patas after oral adminstration of a weakly pathogenic Shigella strain.
Felsenfeld O; Greer WE; Jiricka Z
Lab Invest; 1968 Jul; 19(1):146-52. PubMed ID: 4174914
[No Abstract] [Full Text] [Related]
22. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
[TBL] [Abstract][Full Text] [Related]
23. [Antidysenteric vaccination. XIV. Immunizing action on the guinea pig conjunctiva of various toxic extracts of pathogenic Shigella flexneri 2a TI, as compared with that of live cultures of two non-pathogenic strains of Shigella flexneri 2a].
Istrati M; Istrati G
Arch Roum Pathol Exp Microbiol; 1966 Mar; 25(1):55-64. PubMed ID: 5973711
[No Abstract] [Full Text] [Related]
24. Animal model of human disease. Bacillary dysentery, shigellosis, Shigella dysentery. Animal model: Monkey shigellosis or dysentery.
Takeuchi A; Jervis HR; Formal SB
Am J Pathol; 1975 Oct; 81(1):251-4. PubMed ID: 810032
[No Abstract] [Full Text] [Related]
25. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection.
Phalipon A; Tanguy M; Grandjean C; Guerreiro C; Bélot F; Cohen D; Sansonetti PJ; Mulard LA
J Immunol; 2009 Feb; 182(4):2241-7. PubMed ID: 19201878
[TBL] [Abstract][Full Text] [Related]
26. Bacteriological and epidemiological approaches to the prophylaxis of enteric infection. VI. In vitro studies on the mechanism of acquired resistance to Shigella flexneri infection (1).
Sakaguchi T; Sakaguchi S; Okamoto M; Matsui S; Anzai H
Kitasato Arch Exp Med; 1980 Dec; 53(3-4):97-109. PubMed ID: 7035741
[No Abstract] [Full Text] [Related]
27. Studies in bacillary dysentery. II. Antibody formation in Macacus rhesus monkeys after the oral ingestion of living and formalin-killed cultures of Shigella paradysenteriae.
GONZALEZ LM; ARBONA G; FERNOS J
J Infect Dis; 1950; 87(2):197-200. PubMed ID: 14774538
[No Abstract] [Full Text] [Related]
28. Early colonic lesions in experimental Shigella infection in rhesus monkeys: revisited.
Takeuchi A
Vet Pathol Suppl; 1982 Sep; 19 Suppl 7():1-8. PubMed ID: 6153000
[TBL] [Abstract][Full Text] [Related]
29. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
Jennison AV; Roberts F; Verma NK
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
[TBL] [Abstract][Full Text] [Related]
30. Death from multi-resistant shigellosis in Fiji Islands.
Watson C
Pac Health Dialog; 2001 Mar; 8(1):99-102. PubMed ID: 12017845
[TBL] [Abstract][Full Text] [Related]
31. The response of man to virulent Shigella flexneri 2a.
DuPont HL; Hornick RB; Dawkins AT; Snyder MJ; Formal SB
J Infect Dis; 1969 Mar; 119(3):296-9. PubMed ID: 5780532
[No Abstract] [Full Text] [Related]
32. Studies on acquired systemic resistance in mice with oral immunization with Shigella sonnei.
Kowalewska D; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1980; 28(2):345-55. PubMed ID: 7004395
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapeutic evaluation of rifampicin to experimental bacillary dysentery in cynomolgus monkeys.
Osada Y; Nakajo M; Inaba M; Une T; Ogawa H
Jpn J Microbiol; 1972 Jul; 16(4):275-85. PubMed ID: 4631612
[No Abstract] [Full Text] [Related]
34. Early colonic lesions in experimental Shigella infection in rhesus monkeys: revisited.
Takeuchi A
Vet Pathol Suppl; 1982 Sep; 7():1-8. PubMed ID: 6755871
[TBL] [Abstract][Full Text] [Related]
35. [Anti-dysentery vaccination. 13. Immunogenicity of Sh. flexneri 2A as compared with the immunogenicity of a keratoconjunctivitis-positive enterobacterium devoid of Shigella antigens. Preliminary note].
Ciufeco C; Grigoresco E; Istrati G
Arch Roum Pathol Exp Microbiol; 1965 Sep; 24(3):669-76. PubMed ID: 5877878
[No Abstract] [Full Text] [Related]
36. [Gena types of Shigella enterotoxins of S. flexneri 2a].
Bai S; Li X; Xia G; Yuan H; Zheng W; Wang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):280-2. PubMed ID: 11860800
[TBL] [Abstract][Full Text] [Related]
37. [State of immunogenesis in different methods of treating acute dysentery].
Chernaia TT; Beĭsembaev EA
Klin Med (Mosk); 1980 Feb; 58(2):31-4. PubMed ID: 6988643
[No Abstract] [Full Text] [Related]
38. An outbreak of Shigella flexneri infection among rheus monkeys.
REWELL RE; BRIDGES RF
Mon Bull Minist Health Public Health Lab Serv; 1948 Jan; 7():25-9. PubMed ID: 18915380
[No Abstract] [Full Text] [Related]
39. Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study.
Chompook P; Samosornsuk S; von Seidlein L; Jitsanguansuk S; Sirima N; Sudjai S; Mangjit P; Kim DR; Wheeler JG; Todd J; Lee H; Ali M; Clemens J; Tapchaisri P; Chaicumpa W
Bull World Health Organ; 2005 Oct; 83(10):739-46. PubMed ID: 16283050
[TBL] [Abstract][Full Text] [Related]
40. Antidysentery immunoprophylaxis in the light of current data about the pathogenicity of Shigella and the antidysentery immunity.
Meitert T
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):195-230. PubMed ID: 6443688
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
